These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25418058)

  • 1. Reply to "The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery".
    Macrì A; Fleres F; Cucinotta E; Catanoso R; Saladino E
    Ren Fail; 2015 Mar; 37(2):357. PubMed ID: 25418058
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M; Robella M; Mellano A; Sottile A; De Simone M
    Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
    Kusamura S; Baratti D; Younan R; Laterza B; Oliva GD; Costanzo P; Favaro M; Gavazzi C; Grosso F; Deraco M
    Ann Surg Oncol; 2007 Sep; 14(9):2550-8. PubMed ID: 17558537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
    Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
    J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale.
    Shen P; Stewart JH; Levine EA
    Curr Probl Cancer; 2009; 33(3):125-41. PubMed ID: 19647612
    [No Abstract]   [Full Text] [Related]  

  • 8. Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
    Sugarbaker PH
    Ann Surg Oncol; 2010 Jun; 17(6):1710-2; author reply 1713-4. PubMed ID: 20354799
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
    Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
    Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC; Yan TD; Morris DL
    J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
    Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
    Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
    Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M
    Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study.
    Macrì A; Arcoraci V; Belgrano V; Caldana M; Cioppa T; Costantini B; Cucinotta E; De Cian F; De Iaco P; De Manzoni G; Di Giorgio A; Fleres F; Muffatti F; Orsenigo E; Pinna AD; Roviello F; Sammartino P; Scambia G; Saladino E
    Anticancer Res; 2014 Oct; 34(10):5689-93. PubMed ID: 25275075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review.
    Seretis C; Youssef H
    Eur J Surg Oncol; 2014 Dec; 40(12):1605-13. PubMed ID: 25242382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
    Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
    Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.
    Cascales Campos PA; Gil Martínez J; Galindo Fernández PJ; Gil Gómez E; Martínez Frutos IM; Parrilla Paricio P
    Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chia CS; Tan WJ; Wong JF; Tan GH; Lim C; Wang W; Sin EI; Tham CK; Soo KC; Teo MC
    Eur J Surg Oncol; 2014 Aug; 40(8):909-16. PubMed ID: 24768445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of delayed hyperthermic intraperitoneal chemotherapy in case of unforeseen complications.
    Mohr Z; Hirche C; Liebeskind U; Rau B; Hünerbein M
    Eur Surg Res; 2011; 47(1):19-25. PubMed ID: 21540615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.